お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、薬物および遺伝子送達システムの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に薬物および遺伝子送達システム市場を分類しています。
本レポートでは世界の薬物および遺伝子送達システム市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Biogen、Novartis、Gilead Sciences、Sarepta Therapeutics、Alnylam Pharmaceuticals、Amgen、Spark Therapeutics、Akcea Therapeutics、Sunway Biotech、SIBIONO、AnGes、Orchard Therapeutics、Human Stem Cells Institute、Adaptimmune、Krystal Biotech、Vertex Pharmaceuticals、CSL Behring

レポートは薬物および遺伝子送達システムの主要生産者を調査し、主要地域や国の消費状況も提供します。薬物および遺伝子送達システムの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Viral Gene Delivery System
    Non-viral Gene Delivery System

用途別の市場セグメント：
    Diabetes
    Central Nervous System
    Infectious Disease
    Oncology
    Other

本レポートの詳細内容
本レポートは、世界の薬物および遺伝子送達システム市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて薬物および遺伝子送達システム市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の薬物および遺伝子送達システム生産量、成長率、市場シェアを調査している。

二. 消費面では、薬物および遺伝子送達システムの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの薬物および遺伝子送達システム売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の薬物および遺伝子送達システム市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本薬物および遺伝子送達システムのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：薬物および遺伝子送達システムのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 薬物および遺伝子送達システムの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける薬物および遺伝子送達システムの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章薬物および遺伝子送達システムメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：薬物および遺伝子送達システムの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：薬物および遺伝子送達システムの主要メーカーの概要を提供し、製品の説明と仕様、薬物および遺伝子送達システムの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：薬物および遺伝子送達システムの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Drug and Gene Delivery System market is projected to grow from US$ 18420 million in 2025 to US$ 79130 million by 2031, at a Compound Annual Growth Rate (CAGR) of 27.5% during the forecast period.
A Drug and Gene Delivery System refers to the technologies and methods used to transport therapeutic agents, such as drugs or genetic materials (DNA/RNA), into targeted cells or tissues in the body. These systems are designed to enhance the efficacy, safety, and specificity of treatments by controlling the release, localization, and cellular uptake of the therapeutic payload. Delivery systems include a wide range of platforms, such as viral vectors, lipid nanoparticles, polymers, micelles, and physical methods like electroporation. They play a crucial role in gene therapy, cancer treatment, vaccine development, and regenerative medicine.
The drug and gene delivery system market is rapidly expanding, fueled by advancements in nanotechnology, molecular biology, and regenerative medicine. A major driver is the growing demand for targeted therapies that can improve treatment efficacy while minimizing side effects. Gene therapy, mRNA vaccines, and precision medicine approaches are becoming central to treating complex diseases such as cancer, genetic disorders, and viral infections. Additionally, innovations in delivery carriers—such as liposomes, viral vectors, nanoparticles, and hydrogels—are improving the stability, bioavailability, and tissue specificity of therapeutic agents. Rising R&D investments, government funding, and an increase in strategic collaborations between biotechnology companies and academic research institutes are also accelerating the development and commercialization of advanced delivery platforms. Moreover, the success of lipid nanoparticle-based COVID-19 vaccines has boosted confidence in novel delivery systems, further stimulating market growth.
Despite strong momentum, the drug and gene delivery system market faces significant challenges. Ensuring the safe, efficient, and controlled release of therapeutic agents remains complex, particularly when dealing with sensitive molecules like nucleic acids or proteins. Viral vectors, while effective, may trigger immune responses or long-term safety concerns, while non-viral methods often struggle with low transfection efficiency or poor cellular uptake. Manufacturing and scaling advanced delivery systems require sophisticated infrastructure and rigorous quality control, leading to high production costs. Additionally, navigating regulatory pathways for approval is time-consuming and varies greatly across regions, creating hurdles for global market penetration. Intellectual property issues and competition from biosimilars and generic formulations also pose risks to innovation. The high cost of gene and cell therapies, especially in low-income countries, further restricts access and limits widespread adoption.
In terms of production side, this report researches the Drug and Gene Delivery System production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Drug and Gene Delivery System by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Drug and Gene Delivery System, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Drug and Gene Delivery System, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Drug and Gene Delivery System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug and Gene Delivery System sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Drug and Gene Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Drug and Gene Delivery System sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, Sunway Biotech, SIBIONO, etc.

Market Segmentation
By Company
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute
    Adaptimmune
    Krystal Biotech
    Vertex Pharmaceuticals
    CSL Behring

Segment by Type
    Viral Gene Delivery System
    Non-viral Gene Delivery System

Segment by Application
    Diabetes
    Central Nervous System
    Infectious Disease
    Oncology
    Other

Production by Region
    North America
    Europe
    Asia-Pacific
    Latin America
    Middle East & Africa

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Drug and Gene Delivery System production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Drug and Gene Delivery System in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Drug and Gene Delivery System manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug and Gene Delivery System sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

List of Tables
 Table 1. Global Drug and Gene Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Viral Gene Delivery System
 Table 3. Key Players of Non-viral Gene Delivery System
 Table 4. Global Drug and Gene Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Drug and Gene Delivery System Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Market Size by Region (2020-2031) & (US$ Million)
 Table 7. Global Drug and Gene Delivery System Market Share by Region (2020-2031)
 Table 8. Market Trends
 Table 9. Market Drivers
 Table 10. Market Challenges
 Table 11. Market Restraints
 Table 12. Global Drug and Gene Delivery System Revenue by Players (2020-2025) & (US$ Million)
 Table 13. Global Drug and Gene Delivery System Market Share by Players (2020-2025)
 Table 14. Global Top Drug and Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug and Gene Delivery System as of 2024)
 Table 15. Global Drug and Gene Delivery System Industry Ranking 2023 VS 2024
 Table 16. Global 5 Largest Players Market Share by Drug and Gene Delivery System Revenue (CR5 and HHI) & (2020-2025)
 Table 17. Global Key Players of Drug and Gene Delivery System, Headquarters and Area Served
 Table 18. Global Key Players of Drug and Gene Delivery System, Product and Application
 Table 19. Global Key Players of Drug and Gene Delivery System, Date of Enter into This Industry
 Table 20. Mergers & Acquisitions, Expansion Plans
 Table 21. Global Market Size by Type (2020-2025) & (US$ Million)
 Table 22. Global Drug and Gene Delivery System Revenue Market Share by Type (2020-2025)
 Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 24. Global Drug and Gene Delivery System Revenue Market Share by Type (2026-2031)
 Table 25. Global Market Size by Application (2020-2025) & (US$ Million)
 Table 26. Global Drug and Gene Delivery System Revenue Market Share by Application (2020-2025)
 Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 28. Global Drug and Gene Delivery System Revenue Market Share by Application (2026-2031)
 Table 29. North America Market Size by Type (2020-2031) & (US$ Million)
 Table 30. North America Market Size by Application (2020-2031) & (US$ Million)
 Table 31. North America Drug and Gene Delivery System Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Market Size by Country (2020-2031) & (US$ Million)
 Table 33. Europe Market Size by Type (2020-2031) & (US$ Million)
 Table 34. Europe Market Size by Application (2020-2031) & (US$ Million)
 Table 35. Europe Drug and Gene Delivery System Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Market Size by Country (2020-2025) & (US$ Million)
 Table 37. China Market Size by Type (2020-2031) & (US$ Million)
 Table 38. China Market Size by Application (2020-2031) & (US$ Million)
 Table 39. Asia Market Size by Type (2020-2031) & (US$ Million)
 Table 40. Asia Market Size by Application (2020-2025) & (US$ Million)
 Table 41. Asia Drug and Gene Delivery System Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia Market Size by Region (2020-2031) & (US$ Million)
 Table 43. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
 Table 44. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
 Table 45. Middle East, Africa, and Latin America Drug and Gene Delivery System Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
 Table 47. Biogen Company Details
 Table 48. Biogen Business Overview
 Table 49. Biogen Drug and Gene Delivery System Product
 Table 50. Biogen Revenue (2020-2025) & (US$ Million)
 Table 51. Biogen Recent Development
 Table 52. Novartis Company Details
 Table 53. Novartis Business Overview
 Table 54. Novartis Drug and Gene Delivery System Product
 Table 55. Novartis Revenue (2020-2025) & (US$ Million)
 Table 56. Novartis Recent Development
 Table 57. Gilead Sciences Company Details
 Table 58. Gilead Sciences Business Overview
 Table 59. Gilead Sciences Drug and Gene Delivery System Product
 Table 60. Gilead Sciences Revenue (2020-2025) & (US$ Million)
 Table 61. Gilead Sciences Recent Development
 Table 62. Sarepta Therapeutics Company Details
 Table 63. Sarepta Therapeutics Business Overview
 Table 64. Sarepta Therapeutics Drug and Gene Delivery System Product
 Table 65. Sarepta Therapeutics Revenue (2020-2025) & (US$ Million)
 Table 66. Sarepta Therapeutics Recent Development
 Table 67. Alnylam Pharmaceuticals Company Details
 Table 68. Alnylam Pharmaceuticals Business Overview
 Table 69. Alnylam Pharmaceuticals Drug and Gene Delivery System Product
 Table 70. Alnylam Pharmaceuticals Revenue (2020-2025) & (US$ Million)
 Table 71. Alnylam Pharmaceuticals Recent Development
 Table 72. Amgen Company Details
 Table 73. Amgen Business Overview
 Table 74. Amgen Drug and Gene Delivery System Product
 Table 75. Amgen Revenue (2020-2025) & (US$ Million)
 Table 76. Amgen Recent Development
 Table 77. Spark Therapeutics Company Details
 Table 78. Spark Therapeutics Business Overview
 Table 79. Spark Therapeutics Drug and Gene Delivery System Product
 Table 80. Spark Therapeutics Revenue (2020-2025) & (US$ Million)
 Table 81. Spark Therapeutics Recent Development
 Table 82. Akcea Therapeutics Company Details
 Table 83. Akcea Therapeutics Business Overview
 Table 84. Akcea Therapeutics Drug and Gene Delivery System Product
 Table 85. Akcea Therapeutics Revenue (2020-2025) & (US$ Million)
 Table 86. Akcea Therapeutics Recent Development
 Table 87. Sunway Biotech Company Details
 Table 88. Sunway Biotech Business Overview
 Table 89. Sunway Biotech Drug and Gene Delivery System Product
 Table 90. Sunway Biotech Revenue (2020-2025) & (US$ Million)
 Table 91. Sunway Biotech Recent Development
 Table 92. SIBIONO Company Details
 Table 93. SIBIONO Business Overview
 Table 94. SIBIONO Drug and Gene Delivery System Product
 Table 95. SIBIONO Revenue (2020-2025) & (US$ Million)
 Table 96. SIBIONO Recent Development
 Table 97. AnGes Company Details
 Table 98. AnGes Business Overview
 Table 99. AnGes Drug and Gene Delivery System Product
 Table 100. AnGes Revenue (2020-2025) & (US$ Million)
 Table 101. AnGes Recent Development
 Table 102. Orchard Therapeutics Company Details
 Table 103. Orchard Therapeutics Business Overview
 Table 104. Orchard Therapeutics Drug and Gene Delivery System Product
 Table 105. Orchard Therapeutics Revenue (2020-2025) & (US$ Million)
 Table 106. Orchard Therapeutics Recent Development
 Table 107. Human Stem Cells Institute Company Details
 Table 108. Human Stem Cells Institute Business Overview
 Table 109. Human Stem Cells Institute Drug and Gene Delivery System Product
 Table 110. Human Stem Cells Institute Revenue (2020-2025) & (US$ Million)
 Table 111. Human Stem Cells Institute Recent Development
 Table 112. Adaptimmune Company Details
 Table 113. Adaptimmune Business Overview
 Table 114. Adaptimmune Drug and Gene Delivery System Product
 Table 115. Adaptimmune Revenue (2020-2025) & (US$ Million)
 Table 116. Adaptimmune Recent Development
 Table 117. Krystal Biotech Company Details
 Table 118. Krystal Biotech Business Overview
 Table 119. Krystal Biotech Drug and Gene Delivery System Product
 Table 120. Krystal Biotech Revenue (2020-2025) & (US$ Million)
 Table 121. Krystal Biotech Recent Development
 Table 122. Vertex Pharmaceuticals Company Details
 Table 123. Vertex Pharmaceuticals Business Overview
 Table 124. Vertex Pharmaceuticals Drug and Gene Delivery System Product
 Table 125. Vertex Pharmaceuticals Revenue (2020-2025) & (US$ Million)
 Table 126. Vertex Pharmaceuticals Recent Development
 Table 127. CSL Behring Company Details
 Table 128. CSL Behring Business Overview
 Table 129. CSL Behring Drug and Gene Delivery System Product
 Table 130. CSL Behring Revenue (2020-2025) & (US$ Million)
 Table 131. CSL Behring Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Drug and Gene Delivery System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 2. Global Drug and Gene Delivery System Market Share by Type: 2024 VS 2031
 Figure 3. Viral Gene Delivery System Features
 Figure 4. Non-viral Gene Delivery System Features
 Figure 5. Global Drug and Gene Delivery System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Global Drug and Gene Delivery System Market Share by Application: 2024 VS 2031
 Figure 7. Diabetes Case Studies
 Figure 8. Central Nervous System Case Studies
 Figure 9. Infectious Disease Case Studies
 Figure 10. Oncology Case Studies
 Figure 11. Other Case Studies
 Figure 12. Drug and Gene Delivery System Report Years Considered
 Figure 13. Global Drug and Gene Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Drug and Gene Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Drug and Gene Delivery System Market Share by Region: 2024 VS 2031
 Figure 16. Global Drug and Gene Delivery System Market Share by Players in 2024
 Figure 17. Global Top Drug and Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug and Gene Delivery System as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Drug and Gene Delivery System Revenue in 2024
 Figure 19. North America Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Drug and Gene Delivery System Market Share by Type (2020-2031)
 Figure 21. North America Drug and Gene Delivery System Market Share by Application (2020-2031)
 Figure 22. North America Drug and Gene Delivery System Market Share by Country (2020-2031)
 Figure 23. United States Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Drug and Gene Delivery System Market Share by Type (2020-2031)
 Figure 27. Europe Drug and Gene Delivery System Market Share by Application (2020-2031)
 Figure 28. Europe Drug and Gene Delivery System Market Share by Country (2020-2031)
 Figure 29. Germany Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. China Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. China Drug and Gene Delivery System Market Share by Type (2020-2031)
 Figure 37. China Drug and Gene Delivery System Market Share by Application (2020-2031)
 Figure 38. Asia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Asia Drug and Gene Delivery System Market Share by Type (2020-2031)
 Figure 40. Asia Drug and Gene Delivery System Market Share by Application (2020-2031)
 Figure 41. Asia Drug and Gene Delivery System Market Share by Region (2020-2031)
 Figure 42. Japan Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. South Korea Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. China Taiwan Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Southeast Asia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. India Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Australia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Share by Type (2020-2031)
 Figure 50. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Share by Application (2020-2031)
 Figure 51. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Share by Country (2020-2031)
 Figure 52. Brazil Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Mexico Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Turkey Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 56. Israel Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 57. GCC Countries Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 58. Biogen Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 59. Novartis Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 60. Gilead Sciences Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 61. Sarepta Therapeutics Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 62. Alnylam Pharmaceuticals Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 63. Amgen Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 64. Spark Therapeutics Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 65. Akcea Therapeutics Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 66. Sunway Biotech Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 67. SIBIONO Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 68. AnGes Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 69. Orchard Therapeutics Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 70. Human Stem Cells Institute Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 71. Adaptimmune Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 72. Krystal Biotech Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 73. Vertex Pharmaceuticals Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 74. CSL Behring Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed